CF PHARMTECH (02652) repurchased 67,900 shares for HKD 489,100 on September 29.
CF PHARMTECH (02652) announced that on September 29, 2026, the company repurchased 67,900 shares for HKD 489,100, at a repurchase price of HKD 7.17-7.24 per share.
CF PHARMTECH (02652) announced that on September 29, 2026, it repurchased 67,900 shares for HKD 489,100, at a repurchase price of HKD 7.17-7.24 per share.
Related Articles
GREEN POWER GP (01870) proposes rights issue on a "4-for-1" basis.
CANGGANGRAILWAY (02169) proposes to issue 600 million shares at a discount of approximately 7.29%, raising net proceeds of approximately HK$299.2 million.
DUALITYBIO-B (09606) issued a total of 78,100 shares upon exercise of share options.
GREEN POWER GP (01870) proposes rights issue on a "4-for-1" basis.
CANGGANGRAILWAY (02169) proposes to issue 600 million shares at a discount of approximately 7.29%, raising net proceeds of approximately HK$299.2 million.
DUALITYBIO-B (09606) issued a total of 78,100 shares upon exercise of share options.
